Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001717972-26-000003
Filing Date
2026-01-06
Accepted
2026-01-06 16:15:06
Documents
1
Period of Report
2026-01-02

Document Format Files

Seq Description Document Type Size
1 form4-01062026_040101.html 4  
1 form4-01062026_040101.xml 4 4044
  Complete submission text file 0001717972-26-000003.txt   5575
Mailing Address 12 HAMMERSMITH GROVE OFFICE 205 LONDON United Kingdom W6 7AP
Business Address 12 HAMMERSMITH GROVE OFFICE 205 LONDON United Kingdom W6 7AP 44-0-20-3457 6900
Silence Therapeutics plc (Issuer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SORRENTO THERAPEUTICS, INC. 4955 DIRECTOR'S PLACE SAN DIEGO CA 92121
Business Address
Lemus David (Reporting) CIK: 0001717972 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39487 | Film No.: 26511649